|
ZNF24 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62470037423645E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.43238762465126E-12 |
| Normal-vs-Stage2 |
3.49520000053616E-07 |
| Normal-vs-Stage3 |
1.24344978758018E-14 |
| Normal-vs-Stage4 |
3.23074900165921E-14 |
| Stage1-vs-Stage2 |
7.944600E-01 |
| Stage1-vs-Stage3 |
1.859920E-02 |
| Stage1-vs-Stage4 |
1.835060E-04 |
| Stage2-vs-Stage3 |
5.422200E-02 |
| Stage2-vs-Stage4 |
3.757800E-03 |
| Stage3-vs-Stage4 |
1.752370E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.66373598126302E-15 |
| Normal-vs-AfricanAmerican |
5.95270000000037E-05 |
| Normal-vs-Asian |
1.68190017468817E-10 |
| Caucasian-vs-AfricanAmerican |
5.731400E-01 |
| Caucasian-vs-Asian |
6.240800E-01 |
| AfricanAmerican-vs-Asian |
4.479600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.71605002114484E-14 |
| Normal-vs-Female |
1.63313806922361E-12 |
| Male-vs-Female |
4.874600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.72789560437536E-11 |
| Normal-vs-Age(41-60Yrs) |
5.02820007852733E-13 |
| Normal-vs-Age(61-80Yrs) |
1.72462044645272E-12 |
| Normal-vs-Age(81-100Yrs) |
8.162600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.003200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.416200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.475200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.632600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.584800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.927200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.99920000000442E-05 |
| Classical-VS-Follicular |
8.158600E-01 |
| Classical-VS-Other |
2.816600E-01 |
| Classical-VS-Normal |
1.59769997232218E-09 |
| Tall-VS-Follicular |
6.221800E-04 |
| Tall-VS-Other |
4.589200E-01 |
| Tall-VS-Normal |
6.75015598972095E-14 |
| Follicular-VS-Other |
3.598600E-01 |
| Follicular-VS-Normal |
1.05220000046202E-07 |
| Other-VS-Normal |
7.582400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.64233079860787E-14 |
| Normal-vs-N1 |
1.40200073772689E-11 |
| N0-vs-N1 |
9.983600E-02 |
|
|
